Azevedo, R. S., Garcia-Manero, G., Jabbour, E., Hammond, D., Chien, K., Kadia, T., Kornblau, S., Ravandi, F., Borthakur, G., Pemmaraju, N., Hwang, H., Huang, X., Schneider, H., Meyer, M., Montalban-Bravo, G. (2025). Phase I study of lower dose CPX-351 combined with venetoclax for patients with higher-risk myelodysplastic syndrome or chronic myelomonocytic leukemia after hypomethylating agents failure. Blood. https://doi.org/10.1182/blood-2025-5645